FDA Eyes Site Tours of Cell and Gene Therapy Manufacturers

To improve its reviewers’ understanding of cell and gene therapy manufacturing, the agency has launched a program that will involve a tour of manufacturing facilities and daily workshops for its staffers.

Scroll to Top